AbCellera Biologics' Grant

AbCellera Biologics raised a round of funding on January 19, 2017. Investors include Bill & Melinda Gates Foundation.

AbCellera Biologics is a privately held company that provides enabling technologies to biotechnology and pharmaceutical partners to accelerate the discovery and development of next-generation monoclon…

Articles about AbCellera Biologics' Grant: